vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and UGI CORP (UGI). Click either name above to swap in a different company.

UGI CORP is the larger business by last-quarter revenue ($2.1B vs $1.2B, roughly 1.7× Alignment Healthcare, Inc.). UGI CORP runs the higher net margin — 14.4% vs 0.9%, a 13.5% gap on every dollar of revenue. On growth, UGI CORP posted the faster year-over-year revenue change (3.9% vs -74.7%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (34.6% CAGR vs -7.5%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

UGI Corporation is a natural gas and electric power distribution company headquartered in King of Prussia, Pennsylvania, with extensive operations in the United States and Europe.

ALHC vs UGI — Head-to-Head

Bigger by revenue
UGI
UGI
1.7× larger
UGI
$2.1B
$1.2B
ALHC
Growing faster (revenue YoY)
UGI
UGI
+78.6% gap
UGI
3.9%
-74.7%
ALHC
Higher net margin
UGI
UGI
13.5% more per $
UGI
14.4%
0.9%
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
34.6%
-7.5%
UGI

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ALHC
ALHC
UGI
UGI
Revenue
$1.2B
$2.1B
Net Profit
$11.4M
$297.0M
Gross Margin
Operating Margin
22.0%
Net Margin
0.9%
14.4%
Revenue YoY
-74.7%
3.9%
Net Profit YoY
-20.8%
EPS (diluted)
$1.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
UGI
UGI
Q1 26
$1.2B
Q4 25
$1.0B
$2.1B
Q3 25
$993.7M
$1.2B
Q2 25
$1.0B
$1.4B
Q1 25
$926.9M
$2.6B
Q4 24
$701.2M
$2.0B
Q3 24
$692.4M
$1.2B
Q2 24
$681.3M
$1.4B
Net Profit
ALHC
ALHC
UGI
UGI
Q1 26
$11.4M
Q4 25
$-11.0M
$297.0M
Q3 25
$3.7M
$-13.0M
Q2 25
$15.7M
$-163.0M
Q1 25
$-9.1M
$479.0M
Q4 24
$-31.1M
$375.0M
Q3 24
$-26.4M
$-273.0M
Q2 24
$-24.0M
$-48.0M
Operating Margin
ALHC
ALHC
UGI
UGI
Q1 26
Q4 25
-1.0%
22.0%
Q3 25
0.8%
1.1%
Q2 25
2.2%
-6.8%
Q1 25
-0.6%
26.6%
Q4 24
-3.2%
24.5%
Q3 24
-2.8%
-20.4%
Q2 24
-2.7%
5.0%
Net Margin
ALHC
ALHC
UGI
UGI
Q1 26
0.9%
Q4 25
-1.1%
14.4%
Q3 25
0.4%
-1.1%
Q2 25
1.5%
-12.0%
Q1 25
-1.0%
18.2%
Q4 24
-4.4%
18.9%
Q3 24
-3.8%
-22.6%
Q2 24
-3.5%
-3.6%
EPS (diluted)
ALHC
ALHC
UGI
UGI
Q1 26
Q4 25
$-0.04
$1.34
Q3 25
$0.02
$-0.08
Q2 25
$0.07
$-0.76
Q1 25
$-0.05
$2.19
Q4 24
$-0.15
$1.74
Q3 24
$-0.14
$-1.26
Q2 24
$-0.13
$-0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
UGI
UGI
Cash + ST InvestmentsLiquidity on hand
$705.6M
$251.0M
Total DebtLower is stronger
$6.0B
Stockholders' EquityBook value
$206.9M
$5.0B
Total Assets
$1.3B
$15.8B
Debt / EquityLower = less leverage
1.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
UGI
UGI
Q1 26
$705.6M
Q4 25
$604.2M
$251.0M
Q3 25
$644.1M
$335.0M
Q2 25
$503.8M
$350.0M
Q1 25
$479.5M
$426.0M
Q4 24
$470.6M
$240.0M
Q3 24
$381.0M
$213.0M
Q2 24
$363.7M
$183.0M
Total Debt
ALHC
ALHC
UGI
UGI
Q1 26
Q4 25
$323.2M
$6.0B
Q3 25
$322.7M
$6.5B
Q2 25
$322.3M
$5.7B
Q1 25
$321.9M
$6.6B
Q4 24
$321.4M
$6.6B
Q3 24
$212.0M
$6.4B
Q2 24
$211.7M
$6.3B
Stockholders' Equity
ALHC
ALHC
UGI
UGI
Q1 26
$206.9M
Q4 25
$179.3M
$5.0B
Q3 25
$161.9M
$4.8B
Q2 25
$141.0M
$4.9B
Q1 25
$108.1M
$5.0B
Q4 24
$99.9M
$4.6B
Q3 24
$114.5M
$4.3B
Q2 24
$123.7M
$4.7B
Total Assets
ALHC
ALHC
UGI
UGI
Q1 26
$1.3B
Q4 25
$1.1B
$15.8B
Q3 25
$1.1B
$15.5B
Q2 25
$1.0B
$15.4B
Q1 25
$895.6M
$15.7B
Q4 24
$782.1M
$15.4B
Q3 24
$692.3M
$15.1B
Q2 24
$716.3M
$15.1B
Debt / Equity
ALHC
ALHC
UGI
UGI
Q1 26
Q4 25
1.80×
1.19×
Q3 25
1.99×
1.37×
Q2 25
2.29×
1.17×
Q1 25
2.98×
1.32×
Q4 24
3.22×
1.44×
Q3 24
1.85×
1.48×
Q2 24
1.71×
1.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
UGI
UGI
Operating Cash FlowLast quarter
$128.7M
$66.0M
Free Cash FlowOCF − Capex
$-155.0M
FCF MarginFCF / Revenue
-7.5%
Capex IntensityCapex / Revenue
10.7%
Cash ConversionOCF / Net Profit
11.27×
0.22×
TTM Free Cash FlowTrailing 4 quarters
$282.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
UGI
UGI
Q1 26
$128.7M
Q4 25
$-50.4M
$66.0M
Q3 25
$144.6M
$90.0M
Q2 25
$29.1M
$289.0M
Q1 25
$16.6M
$684.0M
Q4 24
$-8.7M
$164.0M
Q3 24
$26.2M
$151.0M
Q2 24
$23.5M
$390.0M
Free Cash Flow
ALHC
ALHC
UGI
UGI
Q1 26
Q4 25
$-55.4M
$-155.0M
Q3 25
$139.1M
$-168.0M
Q2 25
$21.1M
$67.0M
Q1 25
$8.4M
$538.0M
Q4 24
$-18.0M
$-47.0M
Q3 24
$16.9M
$-115.0M
Q2 24
$11.8M
$185.0M
FCF Margin
ALHC
ALHC
UGI
UGI
Q1 26
Q4 25
-5.5%
-7.5%
Q3 25
14.0%
-14.4%
Q2 25
2.1%
4.9%
Q1 25
0.9%
20.4%
Q4 24
-2.6%
-2.4%
Q3 24
2.4%
-9.5%
Q2 24
1.7%
13.7%
Capex Intensity
ALHC
ALHC
UGI
UGI
Q1 26
Q4 25
0.5%
10.7%
Q3 25
0.6%
22.1%
Q2 25
0.8%
16.3%
Q1 25
0.9%
5.5%
Q4 24
1.3%
10.6%
Q3 24
1.3%
22.0%
Q2 24
1.7%
15.2%
Cash Conversion
ALHC
ALHC
UGI
UGI
Q1 26
11.27×
Q4 25
0.22×
Q3 25
38.77×
Q2 25
1.86×
Q1 25
1.43×
Q4 24
0.44×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons